GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » Selling and Marketing Expense

ImmunoPrecise Antibodies (STU:TQB) Selling and Marketing Expense : €2.81 Mil (TTM As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is ImmunoPrecise Antibodies Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. ImmunoPrecise Antibodies's Selling and Marketing Expense for the three months ended in Jan. 2025 was €0.88 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jan. 2025 was €2.81 Mil.

ImmunoPrecise Antibodies Selling and Marketing Expense Historical Data

The historical data trend for ImmunoPrecise Antibodies's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Selling and Marketing Expense Chart

ImmunoPrecise Antibodies Annual Data
Trend Dec14 Dec15 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.46 1.96 2.44 2.42

ImmunoPrecise Antibodies Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.44 0.62 0.48 0.83 0.88

ImmunoPrecise Antibodies Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmunoPrecise Antibodies Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » Selling and Marketing Expense
Comparable Companies
KALA FNCH CALC PASG RLMD VYNE SLGL LSTA PMN ALLR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
IPA:USA
Address
Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
Website
https://www.ipatherapeutics.com
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

ImmunoPrecise Antibodies Headlines

No Headlines